Author

Daleen Lopez-Ravnborg

Institution: Symphogen (Denmark)

Observed institution: Symphogen (Denmark)

OpenAlex ID: A5095089705

Phase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer

2026 · Francois Ghiringhelli, Richard Kim, et al. · Journal for ImmunoTherapy of Cancer · 3

Abstract CT133: A phase 1b multicenter study of anti-TIM3 (S095018/Sym023) in combination with anti-PD1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer

2024 · Francois Ghiringhelli, Richard Kim, et al. · Cancer Research · 3

Works count: 2

Citation count: 6

H-index: 2

I10-index: